The P2 receptors for extracellular nucleotides participate in the regulation of almost every physiological process and are widely distributed in the body. 1,2 Nucleotide receptors in the muscular, ...
Ticagrelor is the first reversibly binding oral P2Y 12 receptor antagonist to inhibit platelet activation in patients with coronary artery disease (CAD) 1 and was approved by the US Food and Drug ...
Purinergic signaling plays a major role in the enteric nervous system, where it governs gut motility through a number of P2X and P2Y receptors. The aim of this study was to investigate the P2Y ...
Expert Rev Clin Pharmacol. 2012;5(3):319-336. Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results